A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Bristol-Myers Squibb
Bristol-Myers Squibb
Verastem, Inc.
Providence Health & Services
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Shenzhen Hornetcorn Bio-technology Company, LTD
University of Alabama at Birmingham
University of Alabama at Birmingham
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Northwestern University